US 11150237
Patient-specific biomarkers of Escherichia coli invasion in inflammatory bowel disease
granted A61KA61K38/17A61K9/0053
Quick answer
US patent 11150237 (Patient-specific biomarkers of Escherichia coli invasion in inflammatory bowel disease) held by The Regents of the University of California expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/17, A61K9/0053, A61P, A61P1/00